Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
Background
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
Items 201–300 of 806
Ly, L. V., Sluijter, M., Versluis, M., Luyten, G. P. M., van der Burg, S. H., Melief, C. J. M., Jager, M. J., & van Hall, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2288 · Cited by 50
Nickerson, P. E. B., Ortín-Martínez, A., & Wallace, V. A. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00017 · Cited by 50
“To the first point, delivery of cells to either the vitreous body or into the subretinal space can be achieved via injection through a minor incision, and both sites exhibit some degree of immunoprivilege in response to xenografting (reviewed in Streilein, 2003).”
BackgroundMojibian, M., Harder, B., Hurlburt, A., Bruin, J. E., Asadi, A., & Kieffer, T. J. (2013) · Diabetologia · doi:10.1007/s00125-013-3004-z · Cited by 48
“Despite a general belief that the anterior chamber is an immune privileged area due to its anatomical structure and composition of immune cells and soluble factors [20–22], intraocular islet transplantation has been shown to be well-suited for studying alloimmune responses against pancreatic beta cells [18].”
BackgroundYang, K., Vega, J. L., Hadzipasic, M., Schatzmann Peron, J. P., Zhu, B., Carrier, Y., Masli, S., Rizzo, L. V., & Weiner, H. L. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.12.004 · Cited by 50
“TSP-1 also mediates immune privilege in the eye through this mechanism [21].”
BackgroundUpdate on viral gene therapy clinical trials for retinal diseases
Cheng, S.-Y., & Punzo, C. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.159 · Cited by 49
“Thus, viral gene therapy is more feasible since the immune response is suppressed.(4) The administration route also plays an important role in the success of a therapy and in eliciting an immune response.”
BackgroundHori, J., Taniguchi, H., Wang, M., Oshima, M., & Azuma, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4959 · Cited by 49
“Moreover, the posterior surface of the cornea faces the anterior chamber, which is rich in TGF- 2.(1,2) The fact that the immune-privileged status of the cornea can be abolished by dysfunction of even just one of these molecules suggests that each of these molecules plays a nonredundant or cooperative role in maintain…”
BackgroundResultInfluentialDisturbing the balance: effect of contact lens use on the ocular proteome and microbiome
Boost, M. V., Cho, P., & Wang, Z. (2017) · Clinical and Experimental Optometry · doi:10.1111/cxo.12582 · Cited by 52
“The absence of antigen-bearing cells and the lack of lymphatic drainage of the cornea due to the tight cell junctions prevent antigens reaching the lymph nodes and immune cells entering the tissue, thereby reducing the immune response.(71,72) Even within the cornea there are differences, as the central cornea is not a…”
BackgroundComplement and CD4+ T cells drive context-specific corneal sensory neuropathy
Royer, D. J., Echegaray-Mendez, J., Lin, L., Gmyrek, G. B., Mathew, R., Saban, D. R., Perez, V. L., & Carr, D. J. J. (2019) · eLife · doi:10.7554/elife.48378 · Cited by 50
“Accordingly, ocular inflammation is tightly regulated by various ana- tomic, physiologic, and immunologic mechanisms in order to maintain visual acuity (Amouzegar et al., 2016; Streilein, 2003; Taylor et al., 2018).”
Uyama, H., Mandai, M., & Takahashi, M. (2020) · Development Growth & Differentiation · doi:10.1111/dgd.12704 · Cited by 55
“…the unique immunological environment of the eye, known as immune privilege, by suppressing the infiltration of immune cells and by secreting immunomodulating factors, such as transforming growth factor beta, to suppress destructive activities by immune cells (Streilein, 2003; Sugita et al., 2006).”
BackgroundHysa, E., Cutolo, C. A., Gotelli, E., Paolino, S., Cimmino, M. A., Pacini, G., Pizzorni, C., Sulli, A., Smith, V. M., & Cutolo, M. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102796 · Cited by 51
“to a regulation of the innate and adaptative response, a peripheral tolerance to eye-derived antigens and locally induced immunosuppressive microenvironment [19].”
BackgroundAbsence of Blood and Lymphatic Vessels in the Developing Human Cornea
Cursiefen, C., Rummelt, C., Jünemann, A. G. M., Vorwerk, C. K., Neuhuber, W., Kruse, F. E., & Schroedl, F. (2006) · Cornea · doi:10.1097/01.ico.0000214230.21238.3d · Cited by 48
“Lack of MHC II cells in the central cornea is regarded as 1 essential factor contributing to corneal immune privilege.(3,4) In analogy and with respect to corneal angiogenic privilege, other intrauterine tissues such as the lens and the hyaloid body during development are partly vascularized, but later achieve avascul…”
BackgroundMolecular Mechanisms of Topical Anti-Inflammatory Effects of Lipoxin A4 in Endotoxin-Induced Uveitis
Medeiros, R., Rodrigues, E. B., Figueiredo, C. P., Rodrigues, E. B., Júnior, A. G., Menezes‐de‐Lima, O., Passos, G. F., & Calixto, J. Β. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046870 · Cited by 48
“Any disturbance in homeostasis of the eye can lead to biological malfunctioning and/or diffraction, absorbance, or reflection of photons, resulting in disturbed or diminished vision (Streilein, 2003).”
BackgroundAn eye’s view of T regulatory cells
Stein-Streilein, J., & Taylor, A. W. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606383 · Cited by 48
“Amongst the most-studied models of immune privilege is the model of peripheral tolerance induction in the eye, called anterior chamber-associated immune deviation (ACAID) [41].”
BackgroundResultNovack, G. D., & Robin, A. L. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.634 · Cited by 44
“The healthy eye is an immunologically privileged organ, partly as a result of the blood-eye and blood-retina barriers.(14) Some of those anatomical barriers, as well as the performance issues noted above, make drug administration challenging.”
BackgroundDisease progression pathways of wet AMD: opportunities for new target discovery
Wolf, A. T., Harris, A., Oddone, F., Siesky, B. A., Vercellin, A. C. V., & Ciulla, T. A. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2030706 · Cited by 51
“The eye is a strong candidate for gene therapy because it is easily accessible, has a tight blood-ocular barrier, and can be monitored for functional and structural outcomes non-invasively [26].”
BackgroundGenome editing in the treatment of ocular diseases
Choi, E. H., Suh, S., Sears, A. E., Hołubowicz, R., KEDHAR, S. R., Browne, A., & Palczewski, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01057-2 · Cited by 57
CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection
Parkunan, S. M., Randall, C. B., Astley, R., Furtado, G. C., Lira, S. A., & Callegan, M. C. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0416-173r · Cited by 45
“subretinal space, are devoid of vasculature to maintain the clarity of the visual axis that is required for proper vision [1]; however, during endophthalmitis, immune privilege is compromised as bacteria replicate in the posterior segment and immune cells infiltrate the area, which perturbs the visual axis.”
BackgroundSimultaneous functional imaging of neuronal and photoreceptor layers in living human retina
Pfäffle, C., Spahr, H., Kutzner, L., Burhan, S., Hilge, F., Miura, Y., Hüttmann, G., & Hillmann, D. (2019) · Optics Letters · doi:10.1364/ol.44.005671 · Cited by 46
Taylor, A. W., & Kitaichi, N. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.11.001 · Cited by 49
Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models
Niederkorn, J. Y. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32830edbcb · Cited by 47
Pluripotent stem cell-derived retinal organoid/cells for retinal regeneration therapies: A review
Mandai, M. (2023) · Regenerative Therapy · doi:10.1016/j.reth.2022.12.005 · Cited by 49
“In addition to the eye being an immune-privileged site [41], previous clinical studies have reported a low risk of rejection of fetal retinas after transplantation [7,8].”
BackgroundOcular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
Yu, W., & Wu, Z. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.011 · Cited by 50
Eye on the horizon: The metabolic landscape of the RPE in aging and disease
Hansman, D., Du, J., Casson, R. J., & Peet, D. J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101306 · Cited by 55
Two Different Regulatory T Cell Populations That Promote Corneal Allograft Survival
Cunnusamy, K., Paunicka, K., Reyes, N. S., Yang, W., Chen, P. W., & Niederkorn, J. Y. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6161 · Cited by 47
Leptospiral Uveitis – There Is More to It Than Meets the Eye!
Verma, A., & Stevenson, B. (2012) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2011.01445.x · Cited by 44
“In addition to these soluble immunomodulatory factors, cell-surface receptors in the eye interact with their co-receptors on inflammatory cells and inhibit effector functions and convert effector cells into regulators (Taylor, 1999; Streilein, 2003).”
BackgroundInfluentialCD44 expression in endothelial colony-forming cells regulates neurovascular trophic effect
Sakimoto, S., Marchetti, V., Aguilar, E., Lee, K., Usui, Y., Murinello, S., Bucher, F., Trombley, J., Fallon, R. J., Wagey, R., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89906 · Cited by 45
“eral aspects of these experiments could elicit an immunologic response, even though the eye is considered to be relatively immune privileged (23).”
BackgroundDenniston, A. K., Kottoor, S. H., Khan, I. J., Oswal, K. S., Williams, G. P., Abbott, J., Wallace, G. R., Salmon, M., Rauz, S., Murray, P. I., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001450 · Cited by 53
“ponse that might lead to sight-threatening damage (1, 2).”
BackgroundInnate responses of corneal epithelial cells againstAspergillus fumigatuschallenge
Guo, H., & Wu, X. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00551.x · Cited by 44
Aldebasi, T. M., Albekairy, A. M., Alkatheri, A., Harbi, S. A. A., & Mansour, M. A. (2017) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2017.02.008 · Cited by 45
“a well-organized structure of the eye contributes to corneal transplants high success rates.(2)”
Backgroundde Lange, M. J., Nell, R. J., Lalai, R. N., Versluis, M., Jordanova, E. S., Luyten, G. P. M., Jager, M. J., van der Burg, S. H., Zoutman, W. H., van Hall, T., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0114 · Cited by 42
“Combined, this possibly reflects a negative selection pressure, as immune reactions in the eye could have detrimental effects on delicate structures, leading to impaired vision (32, 33).”
BackgroundMolecular Pathogenesis of Bacillus spp., with Emphasis on the Dairy Industry
Grutsch, A. A., Nimmer, P. S., Pittsley, R. H., Kornilow, K. G., & McKillip, J. L. (2018) · Fine Focus · doi:10.33043/ff.4.2.203-222 · Cited by 43
Wildner, G., & Diedrichs‐Möhring, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00758-z · Cited by 52
Low Immunogenicity and Immunosuppressive Properties of Human ESC- and iPSC-Derived Retinas
Yamasaki, S., Sugita, S., Horiuchi, M., Masuda, T., Fujii, S., Makabe, K., Kawasaki, A., Hayashi, T., Kuwahara, A., Kishino, A., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.021 · Cited by 43
“The eye is a unique immune-privileged site where excessive inflammation is suppressed to protect the visual system (Mochizuki et al., 2013; Streilein, 2003).”
BackgroundSugita, S., Ng, T. F., Schwartzkopff, J., & Streilein, J. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4184 · Cited by 45
“These and other mechanisms help to explain why the eye has been shown experimentally to be an immune privileged site (6, 7), i.”
BackgroundSelf-citationCortisol Biosynthesis in the Human Ocular Surface Innate Immune Response
Susarla, R., Liu, L., Walker, E. A., Bujalska, I. J., Al-Salem, J. A., Williams, G. P., Sreekantam, S., TAYLOR, A. E. R., Tallouzi, M., Southworth, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094913 · Cited by 43
“The cornea is considered to be an immune privileged site exhibiting both immunological ignorance, but also a range of active immunosuppression mechanisms [29] that infer a 90% 5 year survival rate of low risk corneal allografts [30,31].”
BackgroundPersistent RNA virus infections: do PAMPS drive chronic disease?
McCarthy, M. K., & Morrison, T. E. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.01.003 · Cited by 42
“, the reproductive tract, ocular tissue, and the central nervous system [CNS]) are considered to be immune privileged—that is, these tissues have specialized regulatory mechanisms that influence the activation and effector function of the immune response to foreign antigens at these sites [1,2].”
BackgroundThe therapeutic application of mesenchymal stem cells at the ocular surface
Sahu, A., Foulsham, W., Amouzegar, A., Mittal, S. K., & Chauhan, S. K. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.01.006 · Cited by 45
“The relatively subdued ocular inflammatory response to foreign antigenic material has led to the eye being defined as an immuneprivileged site [55].”
BackgroundHori, J., Kunishige, T., & Nakano, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113962 · Cited by 47
Macrophages and Uveitis in Experimental Animal Models
Mérida, S., Palacios, E., Návea, A., & Bosch‐Morell, F. (2015) · Mediators of Inflammation · doi:10.1155/2015/671417 · Cited by 43
Horie, S., Robbie, S. J., Liu, J., Wei-kang, W., Ali, R. R., Bainbridge, J. W., Nicholson, L. B., Mochizuki, M., Dick, A. D., & Copland, D. A. (2013) · Scientific Reports · doi:10.1038/srep03072 · Cited by 46
Bousquet, E., Zhao, M., Ly, A., Leroux les Jardins, G., Goldenberg, B., Naud, M.-C., Jonet, L., Besson-Lescure, B., Jaisser, F., Farman, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049036 · Cited by 40
“In the eye, blood-ocular barriers contribute to protect ocular tissues from inflammatory cells invasion and subsequent tissue damages [19].”
B7+Iris Pigment Epithelial Cells Convert T Cells into CTLA-4+, B7-Expressing CD8+Regulatory T Cells
Sugita, S., Keino, H., Futagami, Y., Takase, H., Mochizuki, M., Stein-Streilein, J., & Streilein, J. W. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1354 · Cited by 41
Self-citationHigh-risk corneal allografts: A therapeutic challenge.
Yu, T., Rajendran, V., Griffith, M., Forrester, J., & Kuffová, L. (2016) · World journal of transplantation · doi:10.5500/wjt.v6.i1.10 · Cited by 40
Condition responsive nanoparticles for managing infection and inflammation in keratitis
Saad, M. A., & Rao, C. M. (2017) · Nanoscale · doi:10.1039/c7nr00922d · Cited by 43
Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium
Busch, C., Annamalai, B., Abdusalamova, K., Reichhart, N., Huber, C., Lin, Y., Jo, E. A. H., Zipfel, P. F., Skerka, C., Wildner, G., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00703 · Cited by 43
Sugita, S., Makabe, K., Fujii, S., Iwasaki, Y., Kamao, H., Shiina, T., Ogasawara, K., & Takahashi, M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.003 · Cited by 44
“Importantly, alloantigen insertion into the subretinal space also induced systemic immune deviation (Streilein, 2003).”
BackgroundChen, H., Yu, C., Chen, M., Chou, S.-H., Chiang, M.-S., Chou, W.-H., Ko, B., Huang, H., Kuo, H., & Ho, H. (2013) · Cell Transplantation · doi:10.3727/096368913x674639 · Cited by 41
“Other APC markers were also low (CD80, 0.3–0.8%, and CD86, 1.3–3.1%).”
BackgroundMethodInfluentialHauswirth, W. W., Alemán, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.107 · Cited by 47
Farooq, S. M., & Ashour, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048635 · Cited by 40
“ACAID is maintained by antigenspecific regulatory T cells (Tregs) [1,2].”
BackgroundMorgan, J. T., Wood, J. A., Walker, N. J., Raghunathan, V. K., Borjesson, D. L., Murphy, C. J., & Russell, P. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0175 · Cited by 39
“HTM cells have previously been reported to express major histocompatibility complex (MHC) proteins(79,80) and have been speculated to play a role in anterior segment-associated immune deviation,(80,81) an intricate system where antigens presented in the eye result in systemic suppression of immune response to that ant…”
Miguel, R. D. V., Cherpes, T. L., Watson, L. J., & McKenna, K. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903411 · Cited by 41
Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells
Hattori, T., Takahashi, H., & Dana, R. (2016) · Cornea · doi:10.1097/ico.0000000000001005 · Cited by 42
Le, V. N. H., Schneider, A.-C., Scholz, R., Bock, F., & Cursiefen, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-24037-3 · Cited by 39
Buela, K.-A. G., & Hendricks, R. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402326 · Cited by 39
“Indeed, the cornea has developed mechanisms to discourage inflammation that are collectively referred to as corneal immune privilege (1).”
BackgroundNishioka, C., Initiative, F. T. A. D. N., Poh, C., & Sun, S.-W. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141239 · Cited by 39
Bosch, J. J., Thompson, J. A., Srivastava, M. K., Iheagwara, U. K., Murray, T. G., Lotem, M., Ksander, B. R., & Ostrand‐Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3770 · Cited by 38
“tolerized (8, 9) and, therefore, be inherently more immunogenic than tumor cells from nonprivileged sites.”
BackgroundBoyd, R. F., Boye, S. L., Conlon, T. J., Erger, K. E., Sledge, D. G., Langohr, I. M., Hauswirth, W. W., Komáromy, A. M., Boye, S. E., Petersen-Jones, S. M., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.31 · Cited by 37
Aqueous cytokine levels in four common uveitis entities
Xu, J., Qin, Y., Chang, R., Tan, H., Wang, Q., Su, G., Cao, Q., Kijlstra, A., & Yang, P. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106021 · Cited by 40
AAV-Mediated Gene Therapy for Retinal Disorders in Large Animal Models
Stieger, K., Lheriteau, E., Moullier, P., & Rolling, F. (2009) · ILAR Journal · doi:10.1093/ilar.50.2.206 · Cited by 37
Retinal Laser Burn-Induced Neuropathy Leads to Substance P-Dependent Loss of Ocular Immune Privilege
Lucas, K., Karamichos, D., Mathew, R., Zieske, J. D., & Stein-Streilein, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103264 · Cited by 37
Elbaz, U., Mireskandari, K., Shen, C., & Ali, A. (2015) · Cornea · doi:10.1097/ico.0000000000000419 · Cited by 36
“The cornea in its native state is completely devoid of vascular components thereby retaining immunoprivilege.(2,3) In the event of infectious keratitis, the resulting immune response and new vessel formation can help to eradicate the invading organism but can cause stromal necrosis, thinning, and scarring that impair…”
BackgroundLiclican, E. L., Nguyen, V., Sullivan, A. B., & Gronert, K. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5455 · Cited by 36
Hydrogels as Carriers for Stem Cell Transplantation
Alvarado‐Velez, M., Pai, S. B., & Bellamkonda, R. V. (2014) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2305753 · Cited by 36
Elevated Aqueous Cytokine Levels in Eyes With Ocular Surface Diseases
Aketa, N., Yamaguchi, T., Asato, T., Yagi-Yaguchi, Y., Suzuki, T., Higa, K., Kurihara, T., Satake, Y., Tsubota, K., & Shimazaki, J. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.09.029 · Cited by 38
Sarkar, A., Junnuthula, V., & Dyawanapelly, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910594 · Cited by 40
Chronic Non-Infectious Uveitis in the Elderly: Epidemiology, Pathophysiology and Management
Gupta, R., & Murray, P. I. (2006) · Drugs & Aging · doi:10.2165/00002512-200623070-00001 · Cited by 39
The Role of Biofilms in Device-Related Infections
Shunmugaperumal, T. (2011) · Journal of Medical Devices · doi:10.1115/1.4003637 · Cited by 35
Foulds, L. M., Boysen, R. I., Crane, M., Yang, Y., Muir, J. A., Smith, A. I., de Kretser, D. M., Hearn, M. T. W., & Hedger, M. P. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.064386 · Cited by 36
“It is now clear that privilege must also involve tissuespecific, localized immunoregulatory mechanisms [12–14].”
BackgroundWang, M., Yoshida, A., Kawashima, H., Ishizaki, M., Takahashi, H., & Hori, J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0787 · Cited by 36
Influence of Immune Privilege on Ocular Tumor Development
McKenna, K. C., & Chen, P. W. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273941003669950 · Cited by 38
Madsen, D., Cantwell, E. R., O'Brien, T., Johnson, P. A., & Mahon, B. P. (2009) · Journal of General Virology · doi:10.1099/vir.0.014175-0 · Cited by 36
“Such limitations might not apply to antigen encountered via the eye; it is well known that powerful immunosuppressive effects can be induced when antigen is introduced to the ocular anterior chamber leading to the phenomenon of anterior-chamber-associated immune deviation (Streilein, 2003).”
BackgroundPankert, M. B., Goyer, B., Zaguia, F., Bareille, M., Perron, M.-C., Liu, X., Cameron, J. D., Proulx, S., & Brunette, I. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14720 · Cited by 40
Sanjurjo-Soriano, C., & Kalatzis, V. (2018) · Neural Plasticity · doi:10.1155/2018/5056279 · Cited by 43
“For example, it is relatively immunoprivileged and has specialized immune responses similar to the ones found in the brain and spinal cord [2, 3].”
Efficient Ocular Delivery of VCP siRNA via Reverse Magnetofection in RHO P23H Rodent Retina Explants
Sen, M., Bassetto, M., Poulhès, F., Zelphati, O., Ueffing, M., & Arango‐González, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020225 · Cited by 36
“Besides, a relative immune privilege due to the blood–retina barrier and low lymph drainage minimizes the risk of undesirable side effects [4].”
BackgroundMohan, K. V., Mishra, A., Muniyasamy, A., Sinha, P., Sahu, P., Kesarwani, A., Jain, K., Nagarajan, P., Scaria, V., Agarwal, M., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02528-x · Cited by 37
“The PBMCs isolated from RP patients were stimulated with Y79 cellular lysate and IL4, IFNg, IL10 and TGF-B1 levels was measured.”
BackgroundInfluentialImmunogenicity and Immune Privilege of Corneal Allografts
Hori, J., & Niederkorn, J. Y. (2007) · KARGER eBooks · doi:10.1159/000099279 · Cited by 38
Sugita, S., Futagami, Y., Horie, S., & Mochizuki, M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.07.015 · Cited by 40
Ocular surgical models for immune and angiogenic responses
Inomata, T., Mashaghi, A., Zazzo, A. D., & Dana, R. (2015) · Journal of Biological Methods · doi:10.14440/jbm.2015.78 · Cited by 35
“Aberrant growth of these vessels in the cornea breaks its immune privilege [5].”
BackgroundDistribution of Non-Gal Antigens in Pig Cornea: Relevance to Corneal Xenotransplantation
Cohen, D., Miyagawa, Y., Mehra, R., Lee, W., Isse, K., Long, C., Ayares, D. L., Cooper, D. K. C., & Hara, H. (2014) · Cornea · doi:10.1097/ico.0000000000000069 · Cited by 35
Occelli, L. M., Schön, C., Seeliger, M. W., Biel, M., Michalakis, S., & Petersen‐Jones, S. M. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.155 · Cited by 37
Macrophages Are Vital in Spontaneous Intraocular Tumor Eradication
Boonman, Z. F. H. M., Schurmans, L. R. H. M., van Rooijen, N., Melief, C. J. M., Toes, R. E. M., & Jager, M. J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1427 · Cited by 34
“It includes the production and action of immunosuppressive cytokines, expression of Fas ligand (FasL), and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).(3,4) FasL and TRAIL are placed at strategic places in the eye, such as corneal epithelium, corneal endothelium, iris vasculature, and retina to ind…”
BackgroundApplications of the Role of α-MSH in Ocular Immune Privilege
Taylor, A. W., & Lee, D. J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6354-3_12 · Cited by 33
Rong, X., Yuan, W., Lü, Y., & Mo, X. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s64100 · Cited by 34
SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis
Alston, C. I., & Dix, R. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00732 · Cited by 38
Mahesh, S. P., Li, Z., Liu, B., Fariss, R. N., & Nussenblatt, R. B. (2006) · European Journal of Immunology · doi:10.1002/eji.200635893 · Cited by 35
VIP and Growth Factors in the Infected Cornea
Jiang, X., McClellan, S. A., Barrett, R. P., Berger, E. A., Zhang, Y., & Hazlett, L. D. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6943 · Cited by 34
“aeruginosa), with a robust and rapid angiogenic response, required to enhance immune defenses.(35,36) We hypothesize that inflammation is reduced through the actions of VIP on proinflammatory cytokines and chemokines, but also, with increased VEGF-A and R2 protein levels, as reported herein, immune cells are better ab…”
BackgroundShao, H., Scott, S.-G., Nakata, C., Hamad, A. R. A., & Chakravarti, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054765 · Cited by 36
“Second, the cornea relies heavily on innate immune functions for barrier protection as adaptive immunity is restricted to ensure its immune privileged status, limit inflammation and maintain clarity [10,11].”
BackgroundEye‐mediated immune tolerance to Type II collagen in arthritis‐prone strains of mice
Farooq, S. M., Kumar, A., & Ashour, H. M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12376 · Cited by 35
“This form of tolerance is mainly characterized by antigen-specific suppression of delayed-type hypersensitivity (DTH) reactions mediated through CD4 afferent T regulatory cells (Tregs) and CD8 efferent Tregs [9, 10].”
BackgroundDeDreu, J., Bowen, C. J., Logan, C. M., Pal‐Ghosh, S., Parlanti, P., Stepp, M. A., & Menko, A. S. (2020) · The FASEB Journal · doi:10.1096/fj.202000289r · Cited by 34
Campbell, I. K., Kinkel, S., Drake, S. F., van Nieuwenhuijze, A. E. M., Hubert, F., Tarlinton, D. M., Heath, W. R., Scott, H. S., & Wicks, I. P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24501 · Cited by 33
Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4
Nakatsugawa, M., Hirohashi, Y., Torigoe, T., Asanuma, H., Takahashi, A., Inoda, S., Kiriyama, K., Nakazawa, E., Harada, K., Takasu, H., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01187.x · Cited by 38
Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson’s Disease?
Zhang, Y., Zhang, X., Yue, Y., & Tian, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.799526 · Cited by 38
“Considering the common embryologic and anatomic characteristics of retinal vascular with the cerebral circulation, microvascular changes in the retina may correlate with vascular changes in the CNS.”
BackgroundInfluentialChtarto, A., Bockstael, O., Tshibangu, T., Witte, O. D., Levivier, M., & Tenenbaum, L. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12065 · Cited by 36
“However, the immune reactions in the brain, an immune-privileged site, could be substantially less efficient from those in other organs, [124] [125] [126].”
BackgroundRegional Immunity and Immune Privilege
Kaplan, H. J., & Niederkorn, J. Y. (2007) · KARGER eBooks · doi:10.1159/000099237 · Cited by 35
Primary Testicular and Intraocular Lymphomas: Two Case Reports and a Review of the Literature
Wallace, D. J., Altemare, C., Shen, D. F., de Smet, M. D., Buggage, R. R., Nussenblatt, R. B., & Chan, C. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.11.002 · Cited by 32
Immune Privilege of the Eye and Fetus: Parallel Universes?
Niederkorn, J. Y., & Wang, S. (2005) · Transplantation · doi:10.1097/01.tp.0000173828.78382.4f · Cited by 34
“The CD4 CD25 regulatory T cell population suppresses the induction of DTH immune cells, whereas the CD8 CD25- population inhibits the expression of antigen-specific DTH. TGF- is the critical AHborne factor that conditions ocular APC to induce ACAID (55).”
BackgroundInfluentialModulation of Ovalbumin-Induced Airway Inflammation and Hyperreactivity by Tolerogenic APC
Zhang-Hoover, J., Finn, P. W., & Stein‐Streilein, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7117 · Cited by 32
Macro- and microglial responses in the fellow eyes contralateral to glaucomatous eyes
Ramirez, A. I., Salazar, J. J., de Hoz, R., Rojas, B., Gallego, B., Salobrar‐García, E., Valiente‐Soriano, F. J., Triviño, A., & Ramirez, J. M. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.05.003 · Cited by 34
Manning, J. C., Caballero, G. G., Knospe, C., Kaltner, H., & Gabius, H. (2017) · Journal of Anatomy · doi:10.1111/joa.12612 · Cited by 33
“For mammalian retina, galectin-1 is an effector in establishing the ocular immune privilege (Ishida et al. 2003; Streilein, 2003), exerting protective roles in ocular inflammation (de Freitas Zanon et al.”
BackgroundOcular manifestations in patients with systemic sclerosis
Luboń, M., Luboń, W., Kucharz, E. J., & Mrukwa–Kominek, E. (2020) · Reumatologia/Rheumatology · doi:10.5114/reum.2020.102004 · Cited by 31
“The retina is characterized by immunologically favored microcirculation, lack of resident fibroblasts and adrenergic vasomotor innervation [29, 30].”
Background
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.